LAUSR

Hannah Reimann,* Anita N. Kremer,* Viktoria Blumenberg, Katja Schmidt, Michael Aigner, Benedikt Jacobs, Nina Eisenhauer, Alina Kämpf, Wolf Rösler, Soraya Kharboutli, Dimitrios Mougiakakos, Vanessa Lang, Christopher Lischer, Pascal Irrgang, Moritz Leppkes, Julio Vera Gonzalez, Gerhard Krönke, Andreas E. Kremer, Matthias Tenbusch, Heiko Bruns, Thomas Harrer, Fabian Müller, Georg Schett, Andreas Mackensen, Marion Subklewe,* and Simon Völkl* Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany; Department of Medicine III, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany; German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany; Laboratory for Translational Cancer Immunology, Gene Center, Ludwig Maximilian University of Munich, Munich, Germany; Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany; Department for Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany; Institute of Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen and University Hospital, Erlangen, Germany; Department of Internal Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany; and Department of Gastroenterology and Hepatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland